Redburn Partners analyst Tristan Van Strien initiates coverage on Constellation Brands (NYSE:STZ) with a Buy rating.
Why Jounce Therapeutics Stock Is Moving Higher Today?
The Board of Directors of Jounce Therapeutics Inc (NASDAQ:JNCE) confirmed that Concentra Biosciences LLC made an unsolicited and non-binding proposal to acquire 100%…